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Aims: The nitric oxide and endothelin systems are key components of a local paracrine hormone network in the
heart. We previously reported that diastolic dysfunction observed in mice lacking the endothelial nitric oxide
synthase (eNOS−/−) can be prevented by a genetic overexpression of ET-1. Sexual dimorphisms have been re-
ported in both ET-1 and NO systems. Particularly, eNOS−/−mice present sex related phenotypic differences.
Main methods: We used the ET-1 transgenic (ET+/+), eNOS−/−, and crossbred ET+/+eNOS−/− mice, and
wild type controls. We measured cardiac function by heart catheterization. Cardiac ventricles were collected
for histological and molecular proﬁling.
Key ﬁndings:We report here that (i) the level of ET-1 expression in eNOS−/−micewas elevated inmales but not
in females. (ii) Left ventricular end-diastolic blood pressure was higher inmale eNOS−/−mice than in females.
(ii) eNOS−/−males but not females developed cardiomyocyte hypertrophy. (iv) Perivascular ﬁbrosis of intra-
cardiac arteries developed in female ET+/+ and eNOS−/−mice but not in males. Additionally, (v) the cardiac
expression ofmetalloprotease-9 was higher in eNOS−/−males compared to females. Finally, (vi) cardiac prote-
ome analysis revealed that the protein abundance of the oxidative stress related enzyme superoxide dismutase
presented with sexual dimorphism in eNOS−/− and ET+/+ mice.
Signiﬁcance: These results indicate that the cardiac phenotypes of ET-1 transgenic mice and eNOS knockout mice
are sex speciﬁc. Since both systems are key players in the pathogenesis of cardiovascular diseases, our ﬁndings
might be important in the context of gender differences in patients with such diseases.© 2013 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).Introduction
Endothelin-1 (ET-1) and nitric oxide (NO) are crucial components for
cardiac function and morphology. Both systems belong to a tightly regu-
lated hormonal network (Slowinski et al., 2007) and a deregulation of
the balance between ET-1 andNOoccurs inmany cardiovascular diseases
(Rossi et al., 2001). Mice lacking the main source of NO, the endothelial
NO synthase (eNOS) (eNOS−/−) develop high blood pressure and age
related cardiac hypertrophy (Li et al., 2004). ET-1 transgenic overexpres-
sion inmice leads to an elevation in expression of some extracellular ma-
trix (ECM) proteins in heart but is not sufﬁcient to alter dramatically
cardiac phenotype and to elevate blood pressure due to probable com-
pensatory effects of theNO system (Hocher et al., 2004).We recently gen-
erated crossbred animals of ET+/+ and eNOS−/−mice to disrupt thesearmacy, Kobe Pharmaceutical
a-ku, Kobe 658-8558, Japan.
.de (N. Vignon-Zellweger).
. This is an open access article undercompensatory effects in ET+/+ mice. In contrast to this hypothesis, the
overexpressionof ET-1 could prevent the cardiacdiastolic dysfunctionob-
served in eNOS−/−mice (Vignon-Zellweger et al., 2011).
Sexual dimorphismhas been observed in both NO and ET systems in
experimentalmodels aswell as in humans. eNOS activity is enhanced by
estrogen at the transcriptional and posttranslational level (Kauser and
Rubanyi, 1997). When male eNOS−/−mice develop hypertrophy, the
females do not and a premature death is observed only in eNOS−/−
males (Li et al., 2004). In rats, eNOS protein levels are signiﬁcantly
higher in the renal medulla of females compared with males
(Neugarten et al., 1997). A higher level of circulating ET-1has beenmea-
sured in men than in women and analysis in transsexual individuals in-
dicated that plasma ET-1 levels might be regulated by sexual hormones
(Polderman et al., 1993). The ratio and the density of ET receptors are
different inmen andwomen leading to a different regulation of the con-
tractile response (Ergul et al., 1998). Pharmacological studies performed
in humans targeting the ET-B receptors have shown that the contribu-
tion of this receptor to vascular tone might differ between women and
men (Kellogg et al., 2001). One reason for the lack of hypertension inthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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males (Taylor et al., 2003). This higher activity could be a response to
a positive control of eNOS expression by sex hormones like 17-beta-
estradiol (Sumi and Ignarro, 2003). Finally, castration in male ET+/+
mice ameliorates renal functions, indicating that androgens control
ET-1 actions (Kalk et al., 2009).
In this article, we explored the differences in cardiac physiology and
morphology observed between male and female ET+/+, eNOS−/−
and crossbred ET+/+eNOS−/−mice.
Material and methods
Mice
We used the previously described ET+/+, eNOS−/−, ET+/+
eNOS−/− mice and the wild type (WT) controls (Quaschning et al.,
2007). Female eNOS−/− mice and male homozygous ET-1 trans-
genic mice were originally used to generate the crossbred animals
(Quaschning et al., 2007). Several backcrossing has been performed to
ensure a homogenous genetic background between the four strains.
Genotypes were conﬁrmed by PCR on genomic DNA. The following
primers speciﬁc for the human endothelin-1 transgenewere used to en-
sure the presence or absence of the transgene (forward: CCCCATTCTA
AGCATAGGGGC; reverse: AGCCAGTGAAGATGGTTGGGG). Primers spe-
ciﬁc for the neomycin resistance (NeoR) cassette inserted in the eNOS
gene (forward: TTGTCAAGACCGACCTGTCC; reverse: ACAAGACCGGCT
TCCATCCG) and primers speciﬁc for the wild type eNOS gene (forward:
AGGACATATGTTTGTCTGCGG and reverse: CTGAGGACTGCACCTGTTCA)
were used to verify the knock-out of the eNOS gene. Typical images of
the ampliﬁcation loaded on gel can be seen in Supplementary Fig. 1.
Mice were kept under standard conditions, fed on a standard rodent
diet and received water ad libitum. Mice were sacriﬁced at the age of
nine months. Hearts were harvested, the atrium was removed and the
ventricles were washed and ﬁxed in paraformaldehyde or snap frozen
in liquid nitrogen.
ET-1 gene expression
RNAwas extracted from the cardiac ventricles and qRT-PCRwasper-
formed as previously described (Vignon-Zellweger et al., 2011). The
primers were designed to amplify both the mouse endogene and
human transgene.
Blood pressure
Systolic blood pressure was measured by the tail cuff method in
awaken and trained mice. Left ventricular systolic and end-diastolic
pressure (LVEDP) was measured by heart catheterization as previously
described (Vignon-Zellweger et al., 2011).
Histology
Cardiac ventricles were prepared, washed in saline, ﬁxed in 4% buff-
ered paraformaldehyde, and dehydrated in a graded alcohol series. Fol-
lowing xylene treatment, organs were embedded in parafﬁn blocks and
cut in serial sections (5 μm) using a Microm HM230 Microtom. Slices
were dewaxed with xylol and descending ethanol series and stained
with 0.1% Sirius red in saturated aqueous picric acid. Pictures from the
left ventricle and septum were taken with 200× magniﬁcence. For
interstitial ﬁbrosis measurement, Sirius red-positive area of every
picture was quantiﬁed using the image processing software ImageJ
(shareware from the NIH, USA) with a threshold derived from a sub-
set of randomly chosen pictures. The Sirius red-positive area was
expressed as a percentage of total tissue area. For perivascular ﬁbrosis
measurement, two independent investigators, who were blinded to
the study groups, graded the ﬁbrosis around cardiac arteries using 5different grades based on the relation between media-diameter and
the diameter of the surrounding collagen ring of the adventitia
(grade 1 = diameter of collagen-ring-wall b 25% in comparison to
diameter of media-wall; grade 2 = 25–50%; grade 3 = 50–75%;
grade 4 = 75–100%; grade 5 = N100%). Cardiac perivascular ﬁbrosis
was then expressed as the mean value of the obtained grades.
Immunohistochemistry
For immunohistochemical staining, 6 μm thick frozen sections of the
cardiac ventricles from nine months old animals were used. For detec-
tion of matrix proteins, rabbit anti-MMP2 (Chemicon AB19167), anti-
MMP9 (Chemicon AB19016), anti-Col I (Chemicon AB765P) and anti-
Col III (Calbiochem 234189) primary antibodies were diluted 1/200
and anti-TIMP4 (Chemicon AB19168) 1/25 in an avidin/biotin normal
serumblocking solution and incubated on slices for 1 h at room temper-
ature. Afterwash steps, binding of the antibodieswas revealed using the
ABC Kit elite Vectastain Rabbit Ig (Vector PK6101). The same procedure
omitting the primary antibodywas used as negative control. Slideswere
photographed with a digital camera plugged to the microscope with
200× magniﬁcence. The relative intensity of the signal was measured
on 8 bit pictures using the threshold function of the software ImageJ
(version 1.37V).
Proteomics
Cardiac proteins were extracted and separated by two-dimensional
electrophoresis and the gels were analyzed as described previously
(Schwab et al., 2011). Brieﬂy, whole hearts (n = 6–9) were homoge-
nized and total proteinswere extracted. The proteinswere ﬁrst separat-
ed according to their isoelectric point and second according to their
molecular weight on a polyacrylamide gel. The proteins separated on
the gels were silver stained. Each spots correspond to a protein species
with a speciﬁc isoelectric point and molecular weight. The intensity of
the spots was analyzed using speciﬁc software. The spots of interest
were excised from the gel and digested. The peptide mixtures were ap-
plied to an electron spray ionizer coupled to amass spectrometer for se-
quencing. This step was performed by the Proteome Factory (Proteome
Factory AG, Berlin, Germany) according to their protocols. The se-
quences of the peptides were matched to the database SwissProt to
identify the proteins.
Statistical analysis
All data are expressed as means ± SEM. Statistical analysis was per-
formed using theMann–Whitney U-test or the Student's T-test as men-
tioned in the ﬁgure captions. A value of p b 0.05 was considered to be
statistically signiﬁcant.
Results
Blood pressure and cardiac function
Systolic blood pressuremeasured by the tail cuff methodwas higher
in both eNOS−/− and ET+/+eNOS−/− mice independently of sex.
Left ventricular systolic blood pressure measured by heart catheteriza-
tion showed no differences, apart from a tendency to higher pressure
in male eNOS−/− compared to male ET+/+eNOS−/− mice (Fig. 1).
This difference was absent in females. The left ventricular end-diastolic
pressure was however elevated in eNOS−/−mice both males and fe-
males but the elevation was two-times stronger in males compared to
females (increase in males: 205%, increase in females: 95%) (Fig. 1).
LVEDP was thus signiﬁcantly higher in eNOS−/− males compared to
males from other genotypes and to eNOS−/− females.
Fig. 1. Systolic blood pressuremeasured by the tail cuff method (SBP, n = 12–18), left ventricular systolic blood pressure (LVSBP) and end-diastolic pressure (LVEDP) (n = 6)measured
by heart catheterization (mm Hg) and heart weight to body weight ratio (mg/g) (n = 12–18). Mean ± sem. Student's T-test *p b 0.05.
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Heart weight to body weight ratio measurement did not reveal any
signiﬁcant differences neither between the genotypes nor between
males and females (Fig. 1). However, cardiomyocyte diametermeasure-
ment indicated a cardiac hypertrophy in the eNOS−/−malemice com-
pared to WT and ET+/+ male mice, which was absent in the females
(Fig. 2). Moreover, whereas no sex-related differences were seen
in WT mice, the cardiomyocyte diameter was larger in ET+/+ andFig. 2. Cardiomyocyte diameter (μm)measured on hematoxylin–eosin stained tissue slices. MaeNOS−/−males compared to females. These differences were no lon-
ger observed in crossbred ET+/+eNOS−/−mice (Fig. 2).
Cardiac ﬁbrosis
ET+/+eNOS−/−male and female mice developed interstitial ﬁbro-
sis compared toWTmice (Fig. 3A). No difference was observed between
ET+/+, eNOS−/− andWTmice. All genetically modiﬁed females devel-
oped perivascular ﬁbrosis whereas only ET+/+eNOS−/− males didnnWhitney U-test *p b 0.05. Representative images are presented; bar represents 10 μm.
Fig. 3. Cardiac interstitial (A) and perivascular (B) ﬁbrosis score measured on Sirius red stained slices (n = 9–11). MannWhitney U-test *p b 0.05. Representative images are presented;
bar represents 100 μm.
Fig. 4. ET-1mRNA expression normalized to HPRT expression measured by real-time PCR
(n = 5–6). Mean ± sem. Student's T-test *p b 0.05.
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pared to males in every genotype (Fig. 3B).
Gene expression and protein abundance
The level of messenger RNA of ET-1 in cardiac ventricles was mea-
sured by real-time PCR. It was doubled in mice overexpressing ET-1,
both males and females. In eNOS−/− and ET+/+eNOS−/− male
mice, the ET-1 mRNA level was also two-times higher than in WT
mice but this was not the case in female mice (Fig. 4).
The expression of key proteins involved in the ﬁbrotic process was in-
vestigated by immunohistochemistry. FemaleWT expressed less collagen
I than male WT, and this relation was inverse in ET+/+eNOS−/−mice
(Fig. 5A; B). Collagen III was modestly up regulated in ET+/+eNOS−/−
mice compared toWT, both sexes taken together (Fig. 5). MMP2 expres-
sion and MMP9 expression were similar between the genotypes. Both
eNOS−/− and ET+/+eNOS−/− females expressed less MMP9 than
the males (Fig. 5A; C). No signiﬁcant differences were observed in
TIMP-4 expression between the groups (data not shown).
The detailed analysis of the cardiac proteome has been presented
previously (Vignon-Zellweger et al., 2011). Herewe show that the num-
ber of protein spots for which the abundance changed compared with
theWTmicewas different inmales and females (Fig. 6A). This indicated
that the proteome of the mice was differently regulated in males and
females because of the genetic manipulations. In particular, the abun-
dance of the antioxidant enzyme SOD1was higher in females compared
with males (Fig. 6B).
Discussion
In the present study, we have compared the cardiac phenotype of
male and female WT, ET+/+, eNOS−/−, and ET+/+eNOS−/−mice.
We have showed that male and female mice are not equal in regard tothe consequences of the genetic knock-out of eNOS. The severity of the di-
astolic dysfunction was twice less in females than in males. Furthermore,
the sexual dimorphism observed in this study was underlined by the
absence of cardiac hypertrophy in eNOS−/− females.
The development of LV dysfunction and myocardial hypertrophy
is more rapid in spontaneously hypertensive male rats than in females
(Tamura et al., 1999). In rats with ascending aorta constriction, heart
failure characterized by diastolic dysfunction develops faster in males
than in females (Douglas et al., 1998). Male but not female AT-1
Fig. 5. A. Metalloprotease 9 (MMP9), metalloprotease 2 (MMP2), collagen I and collagen III expression in the cardiac left ventricle measured as percentage of positive immunostaining
signal of tissue area. (n = 6–9). Mean ± sem. MannWhitney U-test *p b 0.05. Representative images are showed for Collagen I (B) and MMP9 (C); negative controls without primary
antibody are showed. Bar represents 100 μm.
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cardial infarction (Bridgman et al., 2013).
Studies in rats and mice have shown that the lack of estrogens has a
deleterious effect on cardiac diastolic function (Delbeck et al., 2011;
Groban et al., 2008; Wang et al., 2013). In line with this, elderly
women are more susceptible to develop diastolic dysfunction than
men (Ahtarovski et al., 2013; Graça et al., 2014), which might indicate
that estrogens play a role in the development of this pathology. Our fe-
male mice could adapt better from the absence of eNOS than themales.
The underlying mechanisms of this phenomenon are so far unknown.
We hypothesized that in female mice NO might be generated by non-
eNOS source of NO. The cardiac protein abundance of iNOS was howev-
er not different between WT and eNOS−/− mice (in both sexes)
(Vignon-Zellweger et al., 2011). This corroborates previous observa-
tions in the lung of eNOS−/−mice, where iNOS levels are similar com-
pared toWTmice despite a protection observed in femalemice in terms
of vascular remodeling (Miller et al., 2005). The better outcome of the
eNOS−/− females might rely on eNOS-independent protective effects
of estrogens.
Sex hormones control the expression of L-type Ca2+ channels,
which are central actors of the depolarizing current in myocytes and
therefore crucial for heart function (Valverde et al., 2011; Yang et al.,
2012). The potential differential expression of these channels in our
mice might explain our observations. Sex hormones have been shown
to control enzymes implicated in sugar and fatty acid metabolism (Huss
et al., 2004).We have seen that the abundance of key enzymes of the gly-
colytic pathway may be differently regulated in male and female eNOS
−/− mice (Vignon-Zellweger et al., 2011). Female eNOS−/− mice
might favor the utilization of glucose opportunely to prevent reduction
of heart function (Fragasso et al., 2007).
Importantly, the better diastolic function in female eNOS−/−mice
compared to males, might be explained by the lower expression of ET-1
measured in females. Blocking the endothelin pathway has been shown
beneﬁcial for heart function in several animal models (Sakai et al., 1996;
Yamauchi-Kohno et al., 1999). It is however seemingly contradictory
that these arguments tending to prove the negative effects of ET-1 oncardiac function are refuted in our own study by the fact that overex-
pression of ET-1 prevented the development of cardiac dysfunction
in the eNOS−/− mice. Putative reasons for the rescue by the ET-1
overexpression might include a control of the remodeling of small
intra-cardiac arteries by ET-1, a beneﬁcial modiﬁcation of energy
metabolism, as well as a better control of the oxidative stress status
(Vignon-Zellweger et al., 2011). Interestingly the level of ET-1 mRNA
expression was similar to WT not only in eNOS−/− females but also
in ET+/+eNOS−/− mice, despite the ET-1 overexpression. This
might indicate that in case of low NO production the ET-1 gene is
down-regulated in females.
ET-1 is a potent proﬁbrotic hormone but its effects are limited by NO
(Dussaule et al., 2000). In this study, we showed that additional lack of
eNOS in ET+/+mice promotes cardiac interstitial ﬁbrosis independently
from sex. In ET+/+mice, compensatory effects from the NO systemhave
been observed explaining in part the modest cardiac phenotype and in
particular the lack of hypertension (Hocher et al., 2004). The fact that
combination of ET-1 overexpression and eNOS inactivation results in en-
hanced interstitial and perivascular ﬁbrosis in ET+/+eNOS−/− mice
conﬁrmed these observations.
Collagen I and III belong to the ﬁbrillar type of ECM proteins and are
thus responsible for myocardial stiffening and development of systolic
and diastolic dysfunctions (Zile and Brutsaert, 2002; Lopez et al., 2006;
Diez et al., 2002). Collagen III was not more abundant in both male
and female ET+/+eNOS−/− compared to WT, which is in line with
the preserved diastolic function in these groups. Non-ﬁbrillar matrix
proteins must be responsible for the elevation of Sirius red staining in
ET+/+eNOS−/− mice. The other constituents of the matrix are pro-
teoglycans and basementmembrane proteins (e.g. laminin, ﬁbronectin).
Elevation in laminin expression, but not collagen I, has been reported in
cardiac interstitium of ET+/+12 month old male mice (Schwarz et al.,
2002).
In female eNOS−/− and ET+/+eNOS−/−mice, MMP9 expression
was reduced. The sexual hormone 17β-estradiol activates eNOS induced
MMP9 expression (Iwakura et al., 2006). The greater amount of estradiol
production by females could thus explain the greater effect of eNOS
Fig. 6.A: Venn diagrams showing the number of differentially abundant protein species in ET+/+, eNOS−/− and ET+/+eNOS−/−male (left) and female (right) mice compared toWT
(n = 6–9). Size of the circle is proportional to the number of protein species. B: 2-Dimensional electrophoresis proteomics pictures of the spot in the hearts of 3 month old males and
females. For each group, a portion of a typical silver stained gel from one heart is shown. The spots correspond to a protein species with a speciﬁc isoelectric point and molecular weight.
Analysis of the digested protein spot by Liquid Chromatography/Electro-Spray Ionization/Mass Spectrometry indicated that this spot corresponds to superoxide dismutase [Cu–Zn]. The
diagram shows the relative intensity of the spot. n = 6–9; mean ± sem. Student's T-test *p b 0.05.
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case of myocardial infarction, MMP9 is less expressed in female than in
male mice (Wang et al., 2007). In smooth muscle cells, the activity of
MMP9 can be however reduced by eNOS (Gurjar et al., 1999). These con-
ﬂicting results underline the nonlinear relationship between MMP ex-
pression and activity. Indeed, MMP2 activity but not expression is
reduced after L-NAME treatment induced NOS inhibition in rat cardiac
tissue (Spanikova et al., 2008). Even though the gene expression of
MMP2 is regulated by estrogens in cardiac ﬁbroblasts (Mahmoodzadeh
et al., 2010), MMP2 activity if not its expression level might differ be-
tween male and female eNOS−/− and ET+/+eNOS−/−mice.
Perivascular ﬁbrosis affected female ET+/+ and ET+/+eNOS−/−
mice, but not males. Immunostaining techniques used here were un-
suitable for quantiﬁcation of collagen in theperivascular area. Neverthe-
less, perivascular ﬁbrosis is closely related to inﬂammation induced
perivascular macrophage inﬁltration (Kai et al., 2005), which is known
to be regulated by sex hormones (Georgiadou and Sbarouni, 2009).
Finally,ﬁbrosis is a highly dynamic process. In the left cardiac ventri-
cle, perivascular ﬁbrosis can lead to interstitial ﬁbrosis after extension
into the interstitium (Silver et al., 1990). Therefore, ﬁbrillar collagen
deposition in the interstitium represents an advanced stage of ﬁbrosis.
Taking into account that ﬁbrosis is the consequence of an imbalance
between collagen production and degradation by metalloproteases,
the elevated collagen I expression and reduced MMP9 expression
observed only in females together with development of perivascular ﬁ-
brosis, suggested that ET+/+eNOS−/− females developed ﬁbrosis
more rapidly than males. Sexual dimorphisms in cardiac function canbe partially explained by the role of estrogen on collagen expression
pattern (Regitz-Zagrosek et al., 2007). Therefore, the differential pattern
of ECMbetweenmale and female in ET+/+eNOS−/−mice could affect
cardiac functions in both sexes differently.
Conclusion
The genetic deletion of eNOS induced diastolic dysfunction, which
was stronger in males than in females and a cardiac hypertrophy in
males only. The mechanisms by which females were protected from
lack of eNOSmight include a reduced ET-1 expression and a differential
expression pattern of proteins involved in oxidative stress and energy
metabolism.
HD version of this video available for your convenience at http://
endothelins.com/Educational_Media/ET-13_Lectures/.
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